Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-15 · accession 0001415889-25-008557 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-18 | 2025-03-17 | MIRM | Radovich Peter | Pres AND COO | S - Sale+OE | $44.21 | -7,879 | 18.7K | -30% | -$348.3K |
| D | 2025-03-18 | 2025-03-15 | MIRM | Radovich Peter | Pres AND COO | M - OptEx | — | +14.4K | 26.6K | +119% | — |
| D | 2025-03-18 | 2025-03-15 | MIRM | Radovich Peter | Pres AND COO | M - OptEx | $0.00 | -14.4K | 7,220 | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-17 | S | D | 7,879 | $44.21 | 18,672 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-15 | M | A | 14,440 | — | 26,551 | D | — | — | (F1) Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 3 | Derivative | Performance Restricted Stock Units | 2025-03-15 | M | D | 14,440 | $0.00 | 7,220 | D | — · — to — | 14,440 Common Stock | (F1) Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F3) The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026. |